Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients

NCT00654628 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00654628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2007
Completion date
July 1, 2009
Enrollment
173 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia